Inactive Instrument
Zalicus Inc Stock Nasdaq
Stocks
US98887C1053
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 746K 651K 603K 564K 1.06M 70.41M 1.06M 7.15M 2.77M 34.66M 2.8M 2.74M 120M | P/E 2014 |
-0.83x | P/E 2015 | -1.35x |
|---|---|---|---|---|---|
| Enterprise Value | -15.94M -13.89M -12.87M -12.05M -22.59M -1.5B -22.73M -153M -59.16M -740M -59.82M -58.54M -2.57B | EV / Sales 2014 |
14,770,294,750x | EV / Sales 2015 | 83,658,631x |
| Free-Float |
100% | Yield 2014 * |
-
| Yield 2015 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.44% | +1.71% | -10.98% | -6.19% | 43.13B | |
| +3.31% | +5.93% | +310.97% | +534.70% | 34.65B | |
| +2.84% | +2.14% | +9.34% | +41.02% | 30.03B | |
| -1.70% | -7.54% | +8.43% | -21.94% | 28B | |
| -1.90% | -1.56% | +10.24% | +21.21% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +48.76% | +104.27% | 13.14B | |
| -0.57% | -2.43% | +5.08% | +4.79% | 12.53B | |
| -0.26% | +1.15% | +98.13% | +80.47% | 12.25B | |
| Average | +0.41% | +0.73% | +60.00% | +94.79% | 23.61B | |
| Weighted average by Cap. | +0.77% | +1.27% | +65.47% | +110.06% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | 0 0 0 0 0.01 0.38 0.01 0.04 0.01 0.19 0.02 0.01 0.65 | 0.7 0.61 0.57 0.53 0.99 66.14 1 6.72 2.6 32.56 2.63 2.57 113.05 |
| Net income | -41.84M -36.48M -33.79M -31.63M -59.32M -3.95B -59.68M -401M -155M -1.94B -157M -154M -6.75B | -52.19M -45.5M -42.14M -39.45M -73.99M -4.92B -74.44M -500M -194M -2.42B -196M -192M -8.42B |
| Net Debt | -14.18M -12.36M -11.45M -10.72M -20.1M -1.34B -20.22M -136M -52.65M -659M -53.23M -52.09M -2.29B | -16.68M -14.55M -13.47M -12.61M -23.65M -1.57B -23.79M -160M -61.94M -775M -62.62M -61.28M -2.69B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
